Bruker (Bruker) Interest Expense : $-16 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bruker Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bruker's interest expense for the three months ended in Dec. 2023 was $ -4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-16 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bruker's Operating Income for the three months ended in Dec. 2023 was $ 133 Mil. Bruker's Interest Expense for the three months ended in Dec. 2023 was $ -4 Mil. Bruker's Interest Coverage for the quarter that ended in Dec. 2023 was 30.30. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bruker Interest Expense Historical Data

The historical data trend for Bruker's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bruker Interest Expense Chart

Bruker Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-16.00

-14.40

-14.30

-16.10

-16.40

Bruker Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-4.30	-4.20	-3.90	-3.90	-4.40

Bruker Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-16 Mil.

Bruker (NAS:BRKR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bruker's Interest Expense for the three months ended in Dec. 2023 was $-4 Mil. Its Operating Income for the three months ended in Dec. 2023 was $133 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $1,235 Mil.

Bruker's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	133.3	/	-4.4
	=	30.30

The higher the ratio, the stronger the company's financial strength is.

Bruker (Bruker) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bruker Corp (NAS:BRKR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

BKD:Germany

Address

40 Manning Road, Billerica, MA, USA, 01821

Website

https://www.bruker.com

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.

Executives

Frank H Laukien	director, 10 percent owner, officer: CEO, President	C/O BRUKER DALTONICS, 40 MANNING ROAD, BILLERICA MA 01821
Marc A Kastner	director	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Cynthia M Friend	director	C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Richard A Packer	director	9 KENDALL DRIVE, WESTBOROUGH MA 01581
Philip Ma	director	C/O BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Mark Munch	officer: Pres. Bruker Nano Inc.	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Juergen Srega	officer: Group President Bruker CALID	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Burkhard Prause	officer: Pres. & CEO, Bruker EST	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Bonnie H Anderson	director	6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO CA 94080
Martin Gilles Gerard Jean	director	BRUKER CORPORATION, 40 MANNING ROAD, BILLERICA MA 01821
Falko Busse	officer: President, BioSpin Group	40 MANNING ROAD, BILLERICA MA 01821
Gerald N Herman	officer: Vice President, Corp Contr.	55 EXECUTIVE DRIVE, HUDSON NH 03051
Ingen Chris Van	director	395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Richard Kniss	director	395 PAGE MILL RD, MS A3 18, PALO ALTO CA 94306
Adelene Q Perkins	director	C/O INFINITY PHARMACEUTICALS, INC., 780 MEMORIAL DRIVE, CAMBRIDGE MA 02139